Early involvement of death-associated protein kinase promoter hypermethylation in the carcinogenesis of Barrett's esophageal adenocarcinoma and its association with clinical progression

Neoplasia

Volumn 9, Issue 3, 2007, Pages 236-245

  Kuester, Doerthe ^a   Dary, Altaf A ^b   Moskalukz, Christopher C ^c   Krueger, Sabine ^a   Meyer, Frank ^a   Hartig, Roland ^a   Stolte, Manfred ^d   Malfertheiner, Peter ^a   Lippert, Hans ^a   Roessner, Albert ^a   El Rifai, Wael ^b   Schneider Stock, Regine ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^d INSTITUTE OF PATHOLOGY   (Germany)

Author keywords

Barrett's adenocarcinoma; Barrett's metaplasia; DAPK; Inflammation; Reflux esophagitis

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME INACTIVATION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS MUCOSA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; MALE; METHYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REFLUX ESOPHAGITIS; TISSUE MICROARRAY;

EID: 33947400177     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.06802     Document Type: Article

References (37)

1. Devesa SS, Blot WJ, Fraumeni JF Jr (1998). Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83, 2049-2053.
2. Jankowski JA, Wright NA, Meltzer SJ, Triadafilopoulos G, Geboes K, Casson AG, Kerr D, and Young LS (1999). Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol 154, 965-973.
3. Jankowski JA, Harrison RF, Perry I, Balkwill F, and Tselepis C (2000). Barrett's metaplasia. Lancet 356, 2079-2085.
4. Tannapfel A (2004). Molecular findings in Barrett's epithelium. Dig Dis 22, 126-133 (review).
5. Vieth M and Stolte M (2002). Barrett's esophagus and neoplasia: data from the Bayreuth Barrett's archive. Gastroenterology 122, 590-591.
6. Spechler SJ (1999). The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction. Gastroenterology 117, 218-228 (review).
7. Bian YS, Osterheld MC, Fontolliet C, Bosman FT, and Benhattar J (2002). p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus. Gastroenterology 122, 1113-1121.
8. Vieth M, Schneider-Stock R, Rohrich K, May A, Ell C, Markwarth A, Roessner A, Stolte M, and Tannapfel A (2004). INK4a-ARF alterations in Barrett's epithelium, intraepithelial neoplasia and Barrett's adenocarcinoma. Virchows Arch 445, 135-141.
9. Eads CA, Lord RV, Kurumboor SK, Wickramasinghe K, Skinner ML, Long TI, Peters JH, DeMeester TR, Danenberg KD, Danenberg PV, et al. (2000). Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res 60, 5021-5026.
10. Eads CA, Lord RV, Wickramasinghe K, Long TI, Kurumboor SK, Bernstein L, Peters JH, DeMeester SR, DeMeester TR, Skinner KA, et al. (2001). Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res 61, 3410-3418.
11. Klump B, Hsieh CJ, Holzmann K, Gregor M, and Porschen R (1998). Hypermethylation of the CDKN2/p16 promoter during neoplastic progression in Barrett's esophagus. Gastroenterology 115, 1381-1386.
12. Lee OJ, Schneider-Stock R, McChesney PA, Kuester D, Roessner A, Vieth M, Moskaluk CA, and El-Rifai W (2005). Hypermethylation and loss of expression of glutathione peroxidase-3 in Barrett's tumorigenesis. Neoplasia 7, 854-861.
13. Schulmann K, Sterian A, Berki A, Yin J, Sato F, Xu Y, Olaru A, Wang S, Mori Y, Deacu E, et al. (2005). Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk. Oncogene 24, 4138-4148.
14. Deiss LP, Feinstein E, Berissi H, Cohen O, and Kimchi A (1995). Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death. Genes Dev 9, 15-30.
15. 2+/calmodulin-dependent, cytoskeletal-associated protein kinase, with cell death-inducing functions that depend on its catalytic activity. EMBO J 16, 998-1008.
16. Schneider-Stock R, Roessner A, and Ullrich O (2005). DAP-kinase - protector or enemy in apoptotic cell death. Int J Biochem Cell Biol 37, 1763-1767.
17. Cohen O, Inbal B, Kissil JL, Raveh T, Berissi H, Spivak-Kroizaman T, Feinstein E, and Kimchi A (1999). DAP-kinase participates in TNF-alpha - and Fas-induced apoptosis and its function requires the death domain. J Cell Biol 146, 141-148.
18. ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation. Nat Cell Biol 3, 1-7.
19. Esteller M, Corn PG, Baylin SB, and Herman JG (2001). A gene hypermethylation profile of human cancer. Cancer Res 61, 3225-3229.
20. Mittag F, Kuester D, Vieth M, Peters B, Stolte B, Roessner A, and Schneider-Stock R (2006). DAPK promoter methylation is an early event in colorectal carcinogenesis. Cancer Lett 240, 69-75.
21. Anacleto C, Leopoldino AM, Rossi B, Soares FA, Lopes A, Rocha JC, Caballero O, Camargo AA, Simpson AJ, and Pena SD (2005). Colorectal cancer "methylator phenotype": fact or artifact? Neoplasia 7, 331-335.
22. Schneider-Stock R, Kuester D, Ullrich O, Mittag F, Habold C, Boltze C, Peters B, Krueger S, Hintze C, Meyer F, et al. (2006). Close localization of DAP-kinase positive tumor-associated macrophages and apoptotic colorectal cancer cells. J Pathol 209, 95-105.
23. Zhang J, Martins CR, Fansler ZB, Roemer KL, Kincaid EA, Gustafson KS, Heitjan DF, and Clark DP (2005). DNA methylation in anal intraepithelial lesions and anal squamous cell carcinoma. Clin Cancer Res 11, 6544-6549.
24. Brock MV, Gou M, Akiyama Y, Muller A, Wu TT, Montgomery E, Deasel M, Germonpre P, Rubinson L, Heitmiller RF, et al. (2003). Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma. Clin Cancer Res 9, 2912-2919.
25. Brabender J, Marjoram P, Lord RV, Metzger R, Salonga D, Vallbohmer D, Schafer H, Danenberg KD, Danenberg PV, Selaru FM, et al. (2005). The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma. Cancer Epidemiol Biomark Prev 14, 2113-2117.
26. Schildhaus HU, Krockel I, Lippert H, Malfertheiner P, Roessner A, and Schneider-Stock R (2005). Promoter hypermethylation of p16INK4a, E-cadherin, O6-MGMT, DAPK and FHIT in adenocarcinomas of the esophagus, esophagogastric junction and proximal stomach. Int J Oncol 26, 1493-1500.
27. Kang GH, Shim YH, Jung HY, Kim WH, Ro JY, and Rhyu MG (2001). CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res 61, 2847-2851.
28. Kim HC, Kim JC, Roh SA, Yu CS, Yook JH, Oh ST, Kim BS, Park KC, and Chang R (2005). Aberrant CpG island methylation in early-onset sporadic gastric carcinoma. J Cancer Res Clin Oncol 131, 733-740.
29. Inbal B, Cohen O, Polak-Charcon S, Kopolovic J, Vadai E, Eisenbach L, and Kimchi A (1997). DAP kinase links the control of apoptosis to metastasis. Nature 390, 180-184.
30. Tozawa T, Tamura G, Honda T, Nawata S, Kimura W, Makino N, Kawata S, Sugai T, Suto T, and Motoyama T (2004). Promoter hypermethylation of DAP-kinase is associated with poor survival in primary biliary tract carcinoma patients. Cancer Sci 95, 736-740.
31. Tang X, Khuri FR, Lee JJ, Kemp BL, Liu D, Hong WK, and Mao L (2000). Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer. J Natl Cancer Inst 92, 1511-1516.
32. Wittekind C, Meyer HJ, and Bootz F (2002). TNM Classification of Malignant Tumors. Springer, Berlin.
33. Vieth M, Peitz U, Labenz J, Kulig M, Naucler E, Jaspersen D, Meyer-Sabellek W, Willich S, Lind T, Malfertheiner P, et al. (2004). What parameters are relevant for the histological diagnosis of gastroesophageal reflux disease without Barrett's mucosa? Dig Dis 22, 196-201.
34. Baylin SB, Herman JG, Graff JR, Vertino PM, and Issa JP (1998). Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 72, 141-196.
35. Delgado S, Gomez M, Bird A, and Antequera F (1998). Initiation of DNA replication at CpG islands in mammalian chromosomes. EMBO J 17, 2426-2435.
36. 6-methylguanine-DNA-methyltransferase, and deathassociated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res 61, 939-942.
37. Kim DH, Nelson HH, Wiencke JK, Christiani DC, Wain JC, Mark EJ, and Kelsey KT (2001). Promoter methylation of DAP-kinase: association with advanced stage in non-small cell lung cancer. Oncogene 20, 1765-1770.